UBS Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-276,847
Closed -$18.9M 10627
2022
Q3
$18.9M Buy
276,847
+168,360
+155% +$11.5M 0.01% 953
2022
Q2
$3.47M Sell
108,487
-22,618
-17% -$723K ﹤0.01% 2023
2022
Q1
$4.54M Buy
131,105
+21,200
+19% +$734K ﹤0.01% 1999
2021
Q4
$3.22M Sell
109,905
-35,875
-25% -$1.05M ﹤0.01% 2487
2021
Q3
$3.72M Buy
145,780
+87,820
+152% +$2.24M ﹤0.01% 2265
2021
Q2
$2.03M Sell
57,960
-23,171
-29% -$812K ﹤0.01% 2729
2021
Q1
$3.31M Buy
81,131
+71,410
+735% +$2.91M ﹤0.01% 2310
2020
Q4
$421K Buy
9,721
+7,256
+294% +$314K ﹤0.01% 3798
2020
Q3
$136K Sell
2,465
-3,028
-55% -$167K ﹤0.01% 4197
2020
Q2
$347K Sell
5,493
-6,142
-53% -$388K ﹤0.01% 3641
2020
Q1
$594K Sell
11,635
-6,315
-35% -$322K ﹤0.01% 3064
2019
Q4
$1.43M Sell
17,950
-103,815
-85% -$8.25M ﹤0.01% 3043
2019
Q3
$5.91M Buy
121,765
+50,507
+71% +$2.45M ﹤0.01% 1723
2019
Q2
$3.75M Buy
71,258
+47,444
+199% +$2.5M ﹤0.01% 2025
2019
Q1
$1.26M Sell
23,814
-119,066
-83% -$6.3M ﹤0.01% 2753
2018
Q4
$5.87M Buy
142,880
+65,783
+85% +$2.7M ﹤0.01% 1583
2018
Q3
$2.93M Buy
77,097
+6,889
+10% +$262K ﹤0.01% 2304
2018
Q2
$3.17M Sell
70,208
-66,186
-49% -$2.99M ﹤0.01% 2199
2018
Q1
$6.59M Buy
136,394
+102,351
+301% +$4.94M ﹤0.01% 1656
2017
Q4
$1.34M Sell
34,043
-38,127
-53% -$1.5M ﹤0.01% 2804
2017
Q3
$2.24M Buy
72,170
+6,827
+10% +$212K ﹤0.01% 2407
2017
Q2
$1.79M Buy
65,343
+28,120
+76% +$769K ﹤0.01% 2501
2017
Q1
$1.37M Buy
+37,223
New +$1.37M ﹤0.01% 2617
2016
Q3
Sell
-128,813
Closed -$2.14M 6924
2016
Q2
$2.14M Sell
128,813
-3,396
-3% -$56.3K ﹤0.01% 2149
2016
Q1
$2.1M Sell
132,209
-83,222
-39% -$1.32M ﹤0.01% 2107
2015
Q4
$6.97M Buy
+215,431
New +$6.97M ﹤0.01% 1304